Gliadel Marketing For Newly-Diagnosed Glioma Will Highlight Survival Benefit

Guilford's marketing of Gliadel for use in patients undergoing surgery for newly-diagnosed malignant glioma will highlight the survival benefit, the company said after receiving the supplemental indication